We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Editorial: Editor's challenge: Dr. Qingxin Mu - how can nanomedicine approaches advance multi-targeting strategy in combination cancer therapy?
- Authors
Pinheiro, Marina; Qingxin Mu
- Abstract
This document is an editorial published in the journal Frontiers in Oncology. It discusses the use of nanomedicine approaches in combination cancer therapy. The editorial highlights the potential of nanomedicine to improve the outcomes of combination therapy by addressing challenges such as drug circulation and cancer cell specificity. The document includes summaries of five articles that explore different aspects of nanomedicine in combination therapy, including the use of specific inhibitors, nanoparticles loaded with multiple drugs, and autophagy-mediated nanomaterials. The editorial concludes that nanomedicine shows promise for developing more effective cancer combination therapies, but further research is needed.
- Subjects
CANCER treatment; NANOMEDICINE; CYTARABINE; CANCER chemotherapy; ANTINEOPLASTIC combined chemotherapy protocols
- Publication
Frontiers in Oncology, 2024, p1
- ISSN
2234-943X
- Publication type
Article
- DOI
10.3389/fonc.2024.1437497